Search

To understand the role of Medicare Part D stand-alone prescription drug plans in serving rural Medicare beneficiaries, this data note analyzes 2025 Part D enrollment in PDPs and Medicare Advantage drug plans by geographic area nationally and at the state level.

With health officials reporting 800 measles cases in multiple states already this year, most of the public – and most parents – report hearing at least one false claim about measles or the vaccine for it, and many of them aren’t sure what to believe, the latest KFF Tracking Poll…

This poll looks at awareness and concern over the outbreak of measles in the U.S. and finds that a growing share of adults is encountering false claims about the measles vaccines, but many are uncertain whether these claims are true or false. Parents who lean toward believing the false claims are less likely to say they keep their children up to date on routine vaccinations.

KFF resources on U.S. funding for global health, including the range of efforts the U.S. supports, U.S. agencies/departments involved in global health activities, funding trends, and more

Amid debates about proposed cuts to federal Medicaid spending, this brief analyzes key characteristics of children with special health care needs and explores how Medicaid provides them with coverage.

Taken together, if approved, these proposed budget cuts and other changes would fundamentally alter the nation’s HIV response which, along with the many other changes being proposed at HHS, does not bode well for making further gains in the fight against HIV.

This data note analyzes the list of terminated and active awards the Trump Administration recently sent to Congress highlighting to assess the impact on global health awards.

Chronic, non-communicable diseases are the leading cause of death worldwide and make up 8 of the 10 top causes of death in the U.S. Across several chronic diseases, the U.S. has a higher burden of illness than peer nations. The reasons why are complex and include differences in how health…

In a new Trump administration executive order, the Secretary of HHS is directed to work with Congress to implement a change in law to delay negotiation of so-called “small molecule” drugs under the Inflation Reduction Act’s Medicare Drug Price Negotiation Program for an additional 4 years. This brief analyzes how many of the drugs previously selected for negotiation would not have been eligible if this policy had been in place at the time.

This brief describes federal citizenship and immigration status eligibility and eligibility verification requirements for Medicaid. Eligibility for federally-funded coverage under Medicaid and the Children’s Health Insurance Program is limited to U.S. citizens and certain lawfully present immigrants.